Design and evaluation of a dry coated drug delivery system with floating-pulsatile release

Journal of Pharmaceutical Sciences

Volumn 97, Issue 1, 2008, Pages 263-273

  Zou, Hao ^a   Jiang, Xuetao ^a   Kong, Lingshan ^a   Gao, Shen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronotherapy; Floating pulsatile drug delivery; Gamma scintigraphy; Pharmacokinetics; Verapamil hydrochloride

Indexed keywords

VERAPAMIL;

ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; NORMAL HUMAN; PULSATILE DRUG RELEASE; STOMACH;

EID: 38349131146     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21083     Document Type: Article

References (38)

1. Lemmer B. 1999. Chronopharmacokinetics: Implications for drug treatment. J Pharm Pharmacol 51: 887-890.
2. Arvidson NG, Gudbjornson B, Elfman L, Ruden AC, Totternam H, Hallgren R. 1994. Circadian rhythm of secum interleucin-6 in rhematiod arthritis. Ann Rheum Dis 53:521-524.
3. Barnes JP. 1985. Circadian variation in airway function. Am J Med 79:5-9.
4. Fox KM, Mulcahy DA. 1991. Circadian rhythms in cardiovascular diseases. Postgrad Med J 67:S33-S36.
5. Millar-Craig MW, Bishop CN, Raftery EB. 1978. Circadian variation of blood pressure. Lancet 1: 795-797.
6. McTavish D, Sorkin EM. 1989. Verapamil an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension. Drugs 38:19-76.
7. Bussemer T, Peppas NA, Bodmeier R. 2003. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm Biopharm 56:261-270.
8. Bussemer T, Dashevsky A, Bodmeier R. 2003. A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. J Control Release 93:331-339.
9. Sungthongjeen S, Puttipipatkhachorn S, Paeratakul O, Dashevsky A, Bodmeier R. 2004. Development of pulsatile release tablets with swelling and rupturable layers. J Contr Rel 95:147-159.
10. Dashevsky A, Mohamad A. 2006. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD. Eur J Pharm Biopharm 318:124-131.
11. Karavas E, Georgarakis E. 2006. Felodipine nano-dispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int J Pharm 313:189-197.
12. MaGruder PR, Barclay B, Wong PSL, Theeuwes F. 1988. Composition comprising salbutamol. US Patent 4,751,071.
13. Cutler N, Anders R, Stanford S, Stramed J, Awan N, Bultas J, Lahari A, Woroszylska M. 1995. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris. A MJ Cardiol 75:1102-1106.
14. Hedben J, Wilson C, Spiller R, Gilchrist P, Blackshaw E, Frier M, Perkins A. 1999. Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm Res 16:1087-1092.
15. Conte U, Colombo P, La Manna A, Gazzaniga A, Sangalli ME, Giuchedi P. 1989. A new ibuprofen pulsed release oral dosage form. Drug Dev Ind Pharm 15:2583-2596.
16. Conte U, Maggi L. 1996. Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drug of different solubility. Biomaterials 17:889-896.
17. Ghika J, Gashoud JP, Gasser U. 1997. Clinical efficacy and tolerability of a new levodopa/benserazide dual-release formulation in parkinsonian patients. Clin Neuropharmacol 20:130-139.
18. Ueda S, Hata T, Asakura S, Yamaguchi H, Ueda Y. 1994. Development of a novel drug release system, time controlled explosion system (TES). Part 1. Concept and design. J Drug Target 2:35-44.
19. Narisawa S, Nagata M, Hirakawa Y, Kobayshi M, Yoshino H. 1996. An organic acid-induced sigmoidal release system for oral controlled release preparations. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid. J Pharm Sci 85:184-188.
20. Sharma S, Pawar A. 2006. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 313:189-197.
21. Karavas E, Georgarakis E, Bikiaris D. 2006. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm 64:115-126.
22. Badve SS, Sher P, Korde A, Pawar AP. Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2006.07.010.
23. Conte U, Maggi L, Torre ML, Giunchedi P, La Manna A. 1993. Press-coated tablets for time-programmed release of drugs. Biomaterials 14: 1017-1023.
24. Halsas M, Ervasti P, Veski P, Jurjenson H, Marvola M. 1998. Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release. Eur J Drug Metab Pharmacokinet 23:190-196.
25. Lin SY, Li MJ, Lin KH. 2004. Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets. AAPS Pharm Sci Tech 5:e54.
26. Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. 2003. Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int J Pharm 253:13-22.
27. Khanna R, Agarwal SP, Ahuja A. 1997. Muco-adhesive buccal tablets of clotrimazole for oral candidiasis. Drug Dev Ind Pharm 23:831-837.
28. Stops F, Fell JT, Collett JH, Martini LG, Sharma HL, Smith A. 2005. The use of citric acid to perolong the in vivo gastro-retention of a floating dosage form in the fasted state. Int J Pharm 308:8-13.
29. Sinha VR, Mittal BR, Kumria R. 2005. In vivo evaluation of time and site of disintegration of polysaccharaeide tablet prepared for colon-specific drug delivery. Int J Pharm 289:79-85.
30. Lau-Cam CA, Piemontese D. 1998. Simplified reversed-phase HPLC method with spectrophotometric detection for the assay of verapamil in rat plasma1. J Pharm Biomed Anal 2916:1029-1035.
31. Hanada K, Akimoto S, Mitsui K, Hashiguchi M, Ogata H. 1998. Quantitative determination of disopyramide, verapamil and flocainide enantiomers in rat plasma and tissues by high-performance liquid chromatography. J Chromatogr 710:129-135.
32. Garcia MA, Aramayona JJ, Bregante MA, Fraile LJ, Solans C. 1997. Simultaneous determination of verapamil and norverapamil in biological samples by highperformance liqiud chromatography using ultraviolet detection. J Chromatogr 693: 377-382.
33. Deshpande AA, Shah NH, Rhodes CT, Malick W. 1997. Development of a novel controlled-release system for gastric retention. Pharm Res 14:815-819.
34. Brahma NS, Kwon HK. 2000. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 63:235-259.
35. Sato Y, Kawashima Y, Takeuchi H, Yamamotob H, Fujibayashic Y. 2004. Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. J Control Release 98:75-85.
36. Stevens H, Wilson C, Welling P, Bakhshaee M, Binns J, Perkins A, Frier M, Blackshaw E, Framed M, Nichols D, Humphrey M, Wicks S. 2002. Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract. Int J Pharm 236:27-33.
37. Dressman JB. 1986. Comparison of canine and human gastrointestinal physiology. Pharm Res 3: 123-131.
38. Akimoto M, Nagahata N, Furuya A, Fukushima K, Higuchi S, Suwa T. 2000. Gastric pH profiles of beagle dogs and their use as an alternative to human testing. Eur J Pharm Biopharm 49:99-102.